Microvascular Complications of Diabetes: Nephropathy, Retinopathy, and Maculopathy

被引:0
作者
Pistrosch, F. [1 ,2 ]
Furashova, O. [3 ]
Engelmann, K. [3 ]
Hanefeld, M. [1 ,2 ]
机构
[1] Univ Klin Carl Gustav Carus, Med Klin 3, Dresden, Germany
[2] GWT TUD GmbH, Kompetenzzentrum Metabol Vaskulare Med, Fiedlerstr 34, D-01307 Dresden, Germany
[3] Klinikums Chemnitz gGmbH, Augenklin, Chemnitz, Germany
来源
DIABETES STOFFWECHSEL UND HERZ | 2018年 / 27卷 / 01期
关键词
diabetes mellitus; nephropathy; retinopathy; maculopathy; treatment; RANDOMIZED CONTROLLED-TRIAL; RENAL REPLACEMENT THERAPY; MACULAR EDEMA; KIDNEY-DISEASE; THIAZOLIDINEDIONE TREATMENT; PERITONEAL-DIALYSIS; IMPROVED SURVIVAL; GLYCEMIC CONTROL; GLUCOSE CONTROL; MORTALITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nephropathy, retinopathy and macular edema constitute serious microvascular complications in diabetes mellitus. In contrast to macrovascular changes, these complications are closely linked with the quality of metabolic control, and often occur together. Survival prognosis is very poor for patients with diabetes and this fully manifested microvascular damage profile. The fifth and final part of the series on microangiopathy will cover the current state of knowledge in diagnosis and treatment for nephropathy, retinopathy and macular oedema in diabetes mellitus. This will include the risk factors, prognosis and therapy for diabetic nephropathy, including blood glucose and blood glucose control as well as lipid metabolism. Treatment options for end-stage renal deficiency such as haemodialysis, peritoneal dialysis, and kidney transplantation will also be given consideration. Treatment options for diabetic retinopathy and diabetic macular edema will also be presented; these include laser photocoagulation, intra-vitreal and systemic options, and surgical therapy.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 48 条
  • [1] American Diabetes Association, 2017, Diabetes Care, V40, pS88
  • [2] A multimodal approach to diabetic macular edema
    Au, Adrian
    Singh, Rishi P.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (03) : 545 - 553
  • [3] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
    Baigent, Colin
    Landray, Martin J.
    Reith, Christina
    Emberson, Jonathan
    Wheeler, David C.
    Tomson, Charles
    Wanner, Christoph
    Krane, Vera
    Cass, Alan
    Craig, Jonathan
    Neal, Bruce
    Jiang, Lixin
    Hooi, Lai Seong
    Levin, Adeera
    Agodoa, Lawrence
    Gaziano, Mike
    Kasiske, Bertram
    Walker, Robert
    Massy, Ziad A.
    Feldt-Rasmussen, Bo
    Krairittichai, Udom
    Ophascharoensuk, Vuddidhej
    Fellstrom, Bengt
    Holdaas, Hallvard
    Tesar, Vladimir
    Wiecek, Andrzej
    Grobbee, Diederick
    de Zeeuw, Dick
    Gronhagen-Riska, Carola
    Dasgupta, Tanaji
    Lewis, David
    Herrington, William
    Mafham, Marion
    Majoni, William
    Wallendszus, Karl
    Grimm, Richard
    Pedersen, Terje
    Tobert, Jonathan
    Armitage, Jane
    Baxter, Alex
    Bray, Christopher
    Chen, Yiping
    Chen, Zhengming
    Hill, Michael
    Knott, Carol
    Parish, Sarah
    Simpson, David
    Sleight, Peter
    Young, Alan
    Collins, Rory
    [J]. LANCET, 2011, 377 (9784) : 2181 - 2192
  • [4] Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema
    Boyer, David S.
    Yoon, Young Hee
    Belfort, Rubens, Jr.
    Bandello, Francesco
    Maturi, Raj K.
    Augustin, Albert J.
    Li, Xiao-Yan
    Cui, Harry
    Hashad, Yehia
    Whitcup, Scott M.
    [J]. OPHTHALMOLOGY, 2014, 121 (10) : 1904 - 1914
  • [5] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [6] Bundesarztekammer Kassenarztliche Bundesvereinigung, 2010, KASS BUND ARB WISS S
  • [7] Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data
    Chaturvedi, N
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) : 370 - 379
  • [8] Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study
    Chen, Yu-Hsin
    Chiang, Ming-Han
    Liu, Jia-Sin
    Chang, Yu-Kang
    Kuo, Ko-Lin
    Hung, Szu-Chun
    Tai, Hsin-Ling
    Hsu, Chih-Cheng
    Tarng, Der-Cherng
    [J]. PLOS ONE, 2015, 10 (06):
  • [9] Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study
    de Boer, Ian H.
    Sun, Wanjie
    Gao, Xiaoyu
    Cleary, Patricia A.
    Lachin, John M.
    Molitch, Mark E.
    Steff, Michael W.
    Zinman, Bernard
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (10) : 793 - 800
  • [10] Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
    Elman, Michael J.
    Aiello, Lloyd Paul
    Beck, Roy W.
    Bressler, Neil M.
    Bressler, Susan B.
    Edwards, Allison R.
    Ferris, Frederick L., III
    Friedman, Scott M.
    Glassman, Adam R.
    Miller, Kellee M.
    Scott, Ingrid U.
    Stockdale, Cynthia R.
    Sun, Jennifer K.
    [J]. OPHTHALMOLOGY, 2010, 117 (06) : 1064 - U65